These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24594507)

  • 1. Menthol reduces the anticoagulant effect of warfarin by inducing cytochrome P450 2C expression.
    Hoshino M; Ikarashi N; Tsukui M; Kurokawa A; Naito R; Suzuki M; Yokobori K; Ochiai T; Ishii M; Kusunoki Y; Kon R; Ochiai W; Wakui N; Machida Y; Sugiyama K
    Eur J Pharm Sci; 2014 Jun; 56():92-101. PubMed ID: 24594507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of menthol on the pharmacokinetics of triazolam and phenytoin.
    Hoshino M; Ikarashi N; Hirobe R; Hayashi M; Hiraoka H; Yokobori K; Ochiai T; Kusunoki Y; Kon R; Tajima M; Ochiai W; Sugiyama K
    Biol Pharm Bull; 2015; 38(3):454-60. PubMed ID: 25757928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cytochrome P450 mediates interaction between warfarin and Coleus forskohlii extract in vivo and in vitro.
    Yokotani K; Chiba T; Sato Y; Taki Y; Yamada S; Shinozuka K; Murata M; Umegaki K
    J Pharm Pharmacol; 2012 Dec; 64(12):1793-801. PubMed ID: 23146043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis.
    Kusunoki Y; Ikarashi N; Hayakawa Y; Ishii M; Kon R; Ochiai W; Machida Y; Sugiyama K
    Eur J Pharm Sci; 2014 Apr; 54():17-27. PubMed ID: 24413062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes.
    Rulcova A; Prokopova I; Krausova L; Bitman M; Vrzal R; Dvorak Z; Blahos J; Pavek P
    J Thromb Haemost; 2010 Dec; 8(12):2708-17. PubMed ID: 20735727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B; Zhang Z; Lam TT; Zuo Z
    Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
    Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
    Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
    Alnaqeeb M; Mansor KA; Mallah EM; Ghanim BY; Idkaidek N; Qinna NA
    BMC Complement Altern Med; 2019 Jan; 19(1):29. PubMed ID: 30678660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes.
    Kudo T; Endo Y; Taguchi R; Yatsu M; Ito K
    Xenobiotica; 2015 May; 45(5):413-9. PubMed ID: 25470432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
    Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
    Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model.
    Chiba T; Kimura Y; Suzuki S; Tatefuji T; Umegaki K
    J Atheroscler Thromb; 2016 Sep; 23(9):1099-110. PubMed ID: 26947597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Ding T; Zhang Y; Chen A; Tang Y; Liu M; Wang X
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):385-9. PubMed ID: 25250504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatic cytochrome P450 in a mouse model of ulcerative colitis changes with pathological conditions.
    Kusunoki Y; Ikarashi N; Matsuda S; Matsukawa Y; Kitaoka S; Kon R; Tajima M; Wakui N; Ochiai W; Machida Y; Sugiyama K
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1618-26. PubMed ID: 25867644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
    Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
    Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
    Burstein AH; Clark DJ; O'Gorman M; Willavize SA; Brayman TG; Grover GS; Walsky RL; Obach RS; Faessel HM
    J Clin Pharmacol; 2007 Nov; 47(11):1421-9. PubMed ID: 17962429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and warfarin in healthy volunteers.
    Macha S; Rose P; Mattheus M; Pinnetti S; Woerle HJ
    Diabetes Obes Metab; 2013 Apr; 15(4):316-23. PubMed ID: 23094794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.